Literature DB >> 30003844

Barriers to antiretroviral therapy initiation for HIV-positive children aged 2-18 months in Swaziland.

Pauline Jolly1, Luz A Padilla1, Charisse Ahmed1, Chantal Harris1, Nobuhle Mthethwa2, Megha Jha1, Inessa Ba3, Amy Styles4, Sarah P Hope5, Raina Brooks1, Florence Naluyinda-Kitabire6, Makhosini Mamba6, Peter Preko7.   

Abstract

Although early antiretroviral therapy (ART) reduces HIV-related mortality in children by up to 75%, almost half of HIV-positive children younger than 1 year old in Swaziland do not initiate ART. This study was conducted to identify barriers to early ART initiation among HIV-positive infants. This was a case-control study among HIV-positive infants, aged 2 to 18 months, who either did not initiate ART (cases), or initiated ART (controls), during 18 months after testing. Multivariable logistic regression showed that infants who visited the clinic every month, or every 2 months, were 5.78 and 6.20 times more likely to initiate ART than those who visited less often (OR 5.78, 95% CI 1.82-18.33 and OR 6.20, 95% CI 1.30-29.60 respectively). Children who lived ≤30 and 31-60 minutes from the nearest clinic were 84% and 79% less likely respectively to initiate ART (OR 0.16, 95% CI 0.03-0.78 and OR 0.21, 95% CI 0.04-0.98) compared with those who lived more than 60 minutes away. Children who received immunisation after 6 months were 22.59 times more likely to initiate ART (OR 22.59, 95% CI 7.00-21.72) than those who did not. Infants of caregivers who had excellent or good relationships with their healthcare provider were 4.32 times more likely to initiate ART (OR 4.32, 95% CI 1.01-18.59) than those of caregivers who had average or poor relationships with healthcare providers. The significant predictors of ART initiation identified in this study should be regarded as priority areas for intervention among HIV-positive women in Swaziland.

Entities:  

Keywords:  ART initiation; HIV; HIV-positive infants; clinic visits; healthcare providers; immunisation; predictors

Mesh:

Substances:

Year:  2018        PMID: 30003844      PMCID: PMC6186401          DOI: 10.2989/16085906.2018.1488266

Source DB:  PubMed          Journal:  Afr J AIDS Res        ISSN: 1608-5906            Impact factor:   1.300


  12 in total

1.  Making sense of the world's highest HIV rate.

Authors:  Barbara Sibbald
Journal:  CMAJ       Date:  2012-10-22       Impact factor: 8.262

2.  A qualitative analysis of the barriers to antiretroviral therapy initiation among children 2 to 18 months of age in Swaziland.

Authors:  Charisse V Ahmed; Pauline Jolly; Luz Padilla; Musa Malinga; Chantal Harris; Nobuhle Mthethwa; Inessa Ba; Amy Styles; Sarah Perry; Raina Brooks; Florence Naluyinda-Kitabire; Makhosini Mamba; Peter Preko
Journal:  Afr J AIDS Res       Date:  2017-12       Impact factor: 1.300

3.  Factors underlying taking a child to HIV care: implications for reducing loss to follow-up among HIV-infected and -exposed children.

Authors:  Juddy Wachira; Susan E Middlestadt; Rachel Vreeman; Paula Braitstein
Journal:  SAHARA J       Date:  2012

4.  Mortality and clinical outcomes in HIV-infected children on antiretroviral therapy in Malawi, Lesotho, and Swaziland.

Authors:  Mark M Kabue; W Chris Buck; Sebastian R Wanless; Carrie M Cox; Eric D McCollum; A Chantal Caviness; Saeed Ahmed; Maria H Kim; Lineo Thahane; Andrew Devlin; Duncan Kochelani; Peter N Kazembe; Nancy R Calles; Michael B Mizwa; Gordon E Schutze; Mark W Kline
Journal:  Pediatrics       Date:  2012-08-13       Impact factor: 7.124

5.  Factors influencing uptake of HIV care and treatment among children in South Africa - a qualitative study of caregivers and clinic staff.

Authors:  A D Yeap; R Hamilton; S Charalambous; T Dwadwa; G J Churchyard; P W Geissler; A D Grant
Journal:  AIDS Care       Date:  2010-09

6.  Early antiretroviral therapy and mortality among HIV-infected infants.

Authors:  Avy Violari; Mark F Cotton; Diana M Gibb; Abdel G Babiker; Jan Steyn; Shabir A Madhi; Patrick Jean-Philippe; James A McIntyre
Journal:  N Engl J Med       Date:  2008-11-20       Impact factor: 91.245

7.  The impact of HIV and AIDS research: a case study from Swaziland.

Authors:  Alan Whiteside; Fiona E Henry
Journal:  Health Res Policy Syst       Date:  2011-06-16

8.  Missed opportunities of inclusion in a cohort of HIV-infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013.

Authors:  Désiré L Dahourou; Madeleine Amorissani-Folquet; Malik Coulibaly; Divine Avit-Edi; Nicolas Meda; Marguerite Timite-Konan; Vic Arendt; Diarra Ye; Clarisse Amani-Bosse; Roger Salamon; Philippe Lepage; Valériane Leroy
Journal:  J Int AIDS Soc       Date:  2016-03-23       Impact factor: 5.396

9.  Outcome of Different Nevirapine Administration Strategies in Preventin g Mother-to-Child Transmission (PMTCT) Programs in Tanzania and Uganda.

Authors:  Heiko Karcher; Andrea Kunz; Gabriele Poggensee; Paulina Mbezi; Kizito Mugenyi; Gundel Harms
Journal:  J Int AIDS Soc       Date:  2006-04-12       Impact factor: 5.396

10.  "It's my secret": barriers to paediatric HIV treatment in a poor rural South African setting.

Authors:  E W Kimani-Murage; L Manderson; S A Norris; K Kahn
Journal:  AIDS Care       Date:  2012-12-18
View more
  1 in total

1.  Correlates of Uptake of Antiretroviral Therapy in HIV-Positive Orphans and Vulnerable Children Aged 0-14 Years in Tanzania.

Authors:  Amon Exavery; John Charles; Erica Kuhlik; Asheri Barankena; Amal Ally; Tumainiel Mbwambo; Christina Kyaruzi; Godfrey Martin Mubyazi; Levina Kikoyo; Elizabeth Jere
Journal:  HIV AIDS (Auckl)       Date:  2020-07-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.